HSBC HOLDINGS PLC (HSBC): what the price requires
At today's price, HSBC HOLDINGS PLC (HSBC) is priced for 14.3% return on equity. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.
Generated: 2026-07-19 · Exported: 2026-07-20 · Source: https://boothcheck.com/report/HSBC
Headline
| Field | Value |
|---|---|
| Ticker | HSBC |
| Company | HSBC HOLDINGS PLC |
| Sector / Industry | Financial Services |
| Current price | $100.55/sh |
| Composition | Reported and constant currency 34% / Constant currency 33% / Currency translation 0% / Reported 33% |
What The Price Requires (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | financials |
| Price-to-book | 1.97x |
| Return on equity now | 9.6% |
The implied return on book is non-physical at this price-to-book and is suppressed as misleading. The price sits beyond a 12.4% return on equity sustained for 40 years and is not resolvable as a sustainable-ROE point. The rarity read below is the honest signal.
Solve inputs: computed at a 9.2% cost of equity; ROE searched up to the 12.4% ROE ceiling.
How unusual the bet is: extreme
| Reference | Value |
|---|---|
| vs own history | +3.68σ |
| cohort percentile (of 120 peers) | 81 |
| sustained it ~10 years at this level | 62% |
| implied end-window share | 1% |
Valuation X-Ray
The price is supported by earnings-power and relative-multiple and growth-DCF value. A value/asset-supported name, not a pure growth bet.
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 1.28x | 3 | expensive |
| Earnings | 1.03x | 2 | expensive |
| Relative | 0.83x | 3 | justifies |
| Growth | 0.95x | 2 | justifies |
Families that justify the price: Earnings, Relative, Growth
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 3.8%); the inversion above states its own rate.
Per-Model Detail (n=10)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | — | — | no | — |
| Bank Fair Value (P/TBV) | — | $86.73 | 1.16x | yes | TBVPS $59.01 × 1.47x (ROE (TTM) 11.2% / CoE 9.3%, g=5.0% (sustainable: 65% retention × ROE, 5% cap; not the terminal-growth assumption)) |
| Relative Valuation | Relative | $83.39 | 1.21x | yes | P/E 11.55x (blended: static sector reference 10x + trailing (TTM) 15x), scenarios: 9.6x / 11.6x / 13.5x (bear / base = reference held flat / bull), EV/EBITDA N/Ax |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | $136.91 | 0.73x | yes | Stage 1: 20% for 5yr, Stage 2: 3.5% perpetual |
| Simple Excess Return | Asset | $71.75 | 1.40x | yes | BV/sh $59.01, ROE (TTM) 11.2%, ke 9.3% |
| Two-Stage Excess Return | Asset | $78.80 | 1.28x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | $85.81 | 1.17x | yes | Rev $68.3B, growth 9% (input: historical growth; tapered), Terminal P/S: 4.3x / 5.1x / 6.0x (bear / base = today's held flat / bull, cap 8x) |
| Peter Lynch Fair Value | Relative | $120.69 | 0.83x | yes | EPS $6.05, growth 20% (input: historical EPS growth), PEG=0.76 (Undervalued) |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | — | — | no | — |
| Residual Income | Asset | — | — | no | — |
| Graham Number | Asset | $89.62 | 1.12x | yes | √(22.5 × EPS $6.05 × BVPS $59.01) — Graham's conservative floor |
| EV/EBITDA Relative | Relative | — | — | no | — |
| FCF Yield | Earnings | — | — | no | — |
| SBC-Adj FCF Yield | Earnings | — | — | no | — |
| Ben Graham Formula | Earnings | $195.21 | 0.52x | yes | EPS $6.05 × (8.5 + 2×15.0%) × (4.4 / 5.3%) |
| ROIC-Justified P/B | Asset | — | — | no | — |
| P/Sales Sector | Relative | — | — | no | — |
| PEG Fair Value | Relative | $181.04 | 0.56x | yes | EPS $6.05 × (PEG 1.5 × growth 19.9% (input: historical EPS growth)) → PE 29.9x |
| Earnings Yield | Earnings | $65.41 | 1.54x | yes | EPS $6.05 / required return 9.3% (Rf 4.3% + ERP 5.0%) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Share count CAGR (buyback) | -3.6% |
Deposit/float-funded balance sheet: debt is funding, not corporate leverage, and GAAP operating cash flow follows loan flows. Net-debt, interest-coverage, and cash-burn lenses do not apply. The solvency frame for a financial is regulatory capital and payout capacity (CET1, stress buffer, dividends plus buybacks against earnings).
Bullet Takeaways
- HSBC runs a capital-return machine: an ordinary dividend set at half of attributable profit, plus buybacks that have shrunk the share count about 3.6% a year over the last four years, all funded by a restructuring that redeploys cost savings toward Asia.
- The risk sits in the price: a price-to-book close to 2x, near the top of the peer group, for a bank earning about 9.6% on its equity, a return-on-book bet that sits at the most demanding end of the range.
- Near-term tests are the integration of Hang Seng Bank, taken fully private in January 2026, and management's drive to pull the cost-to-income ratio below 50% under the current restructuring.
Bull Case
Begin with what HSBC does with the money it makes, because that is the clearest part of the story. The bank's stated policy is to pay an ordinary dividend of half its attributable profit, and its preferred use of capital after that is buybacks and funding the growth of its core businesses. The 20-F states it in one line: "Our primary use of capital generation is to pay an ordinary dividend of 50% of profit attributable to ordinary shareholders". Those buybacks are not a promise. They show up in the share count, which has fallen about 3.6% a year over the last four years. A holder's slice of the bank grows every year without buying another share.
The second lever is the restructuring itself. Under Georges Elhedery, who became chief executive in September 2024, HSBC has collapsed into four businesses and pulled its investment bank back from Western markets toward Asia and the Middle East. The point is not cost-cutting for its own sake. The 20-F frames it as a redeployment: "we aim to redeploy approximately $1.8bn of additional costs saved from non-strategic activities into these areas over the medium term". Money is being moved out of low-return Western advisory and into higher-return Asian wealth and transaction banking. In January 2026 the bank took Hang Seng Bank fully private, tightening its hold on the Hong Kong market it already dominates.
For the bull, the price is not the obstacle it looks like. On trailing earnings and peer multiples the stock is not expensive, and the growth-adjusted earnings methods put it below where those lenses say it should trade. What the elevated multiple asks is that HSBC sustains a return on equity above its own long-run average, and the restructuring is precisely that mechanism: a leaner cost base, capital concentrated in higher-returning Asian franchises, and a cost-to-income ratio management is driving below 50%. If the return holds, a price-to-book near 2x is not rich for a bank compounding capital at a mid-teens return. That is the bull's whole case, and it rests on execution.
Bear Case
Strip away the restructuring story and look at what a buyer actually pays today. HSBC is a bank whose profits straddle two very different worlds, a mature, low-growth Western operation it is busy shrinking and a faster Asian franchise it is betting on, and the market is paying a price-to-book close to 2x for the combination. That is near the top of its peer group of large banks. On a trailing basis the bank has recently been earning about 9.6% on its equity, a return that would sit comfortably in the middle of the pack. The premium is in the price, not yet in the returns.
Now take the price seriously as a demand on the future. Paying a price-to-book close to 2x for a bank's equity is a bet that its return on that equity climbs well above what it earns now and stays there. Push the current price through that logic and it does not resolve into a comfortable number: it requires a return on equity beyond the top tier that banks in this cohort have historically sustained, held for decades rather than years. Set against HSBC's own record, where returns have averaged well below today's level, that requirement sits at the most demanding end of the range. If the return instead drifts back toward its history, the premium has nothing to stand on, and the price-to-book near 2x compresses toward the level the asset value methods support, a long way below $100.55.
The forces that could stall the return are structural, not cyclical. HSBC's pivot east concentrates its fortunes in Hong Kong and mainland China exactly as that economy slows and as the political relationship between China and the West stays tense; the same Asian tilt that powers the bull case is a single-region bet on the other side of the ledger. The Western businesses being wound down still carry restructuring cost and execution risk, and a bank reorganizing into four units while cutting senior ranks can lose revenue it never meant to lose. Net interest income, the engine of the recent profitability, leans on interest rates staying higher than the last decade's norm. None of these is fatal on its own. Together they are why a bank earning a middling return trades as if the return were already excellent, and the gap between the two is the real position a buyer takes.
Valuation
For a bank, the number that carries the most information is what the price pays for each dollar of book equity, and on that measure HSBC looks stretched. At $100.55 (July 19, 2026) the stock trades at a price-to-book close to 2x, near the top of its peer group, while the bank earns a middling single-digit return on that equity. Read the price the other way, as the return on book it would take to justify that multiple, and the standard frame cannot pin it to a stable point: it demands a return on equity beyond even the top tier a bank in this cohort has historically sustained, held not for a handful of years but for decades. That requirement reads at the most demanding end of the scale.
The odd thing is that most of the other methods defend the price. The earnings-power methods and the peer multiple reach it, and the growth-adjusted earnings methods actually sit above it, marking the stock cheap on that lens. Only the asset value methods land lower, with the price about 1.3x above where they sit. So this is not an expensive stock on trailing earnings; it is a value-and-earnings supported name by those frames. The two readings are not in conflict. The earnings and peer-multiple lenses credit what HSBC earns right now, a trailing return on equity of about 9.6%, in a still-elevated rate environment and after deep cost cuts, and on that footing the price is defensible. The return-on-book frame asks whether that profitability lasts long enough to support a price-to-book close to 2x, and against a history in which the bank's returns have averaged well less, that persistence is the whole bet.
Solvency reads differently for a bank than for an industrial company. Deposits are funding, not leverage, and the cash flows track loan flows rather than any burn, so the frame that matters is capital and payout. Here HSBC is on firm ground: it generates enough capital to pay a dividend at half of attributable profit and still buy back stock, shrinking the share count year after year. What the buyer at $100.55 owns is a well-capitalized, cash-returning bank whose price has already booked the higher return the restructuring is meant to deliver.
Catalysts
The near-term catalysts cluster around execution of the plan. HSBC completed the privatisation of Hang Seng Bank in January 2026, folding its Hong Kong sister brand fully into the group and targeting revenue and cost synergies across the two by 2028. The organizational simplification is running ahead of schedule, with management guiding to about $1.5bn of annualized cost savings by the end of 2026. The first-quarter 2026 print showed pre-tax profit up on the year on resilient net interest income and tighter costs, with revenue of about $18.6 billion.
The capital-return calendar is the other thing to watch. Alongside its 2025 results in February 2026 the bank proposed a final dividend and a further share buyback, continuing the pattern that has steadily reduced the share count. The buyback does double duty here: it returns capital and, by shrinking the equity base, lifts the very return-on-equity figure the price is leaning on. The next quarterly results, and any change to the pace of buybacks, are what move the story from here.
Peer Cohorts (Per Segment, With Filing Citations)
Reported and constant currency / Constant currency +2 more (reported)
- BNS (BANK OF NOVA SCOTIA)
- (no filing in the citation store)
- WFC (WELLS FARGO & COMPANY/MN)
- (no filing in the citation store)
- BAC (BANK OF AMERICA CORP /DE/)
- (no filing in the citation store)
- JPM (JPMORGAN CHASE & CO)
- (no filing in the citation store)
- C (Citigroup Inc)
- (no filing in the citation store)
- COF (CAPITAL ONE FINANCIAL CORP)
- (no filing in the citation store)
- KB (KB Financial Group Inc.)
- (no filing in the citation store)
- HDB (HDFC BANK LIMITED)
- (no filing in the citation store)
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.
Sources
HSBC FY2025 20-F · HSBC restructuring update, 2026 · HSBC restructuring disclosures, 2025-2026 · HSBC, January 2026 · HSBC restructuring disclosures, 2026 · HSBC Q1 2026 results, 2026 · HSBC FY2025 results, February 2026